Division of Emergency Medicine, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, ON, Canada.
KidSIM-ASPIRE Simulation Research Program, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada.
Pediatr Crit Care Med. 2024 Oct 1;25(10):918-927. doi: 10.1097/PCC.0000000000003535. Epub 2024 Jun 5.
An aerosol box aims to reduce the risk of healthcare provider (HCP) exposure to infections during aerosol generating medical procedures (AGMPs), but little is known about its impact on workload of team members. We conducted a secondary analysis of data from a prospective, multicenter, randomized controlled trial evaluating the impact of aerosol box use on patterns of HCP contamination during AGMPs. The objectives of this study are to: 1) evaluate the effect of aerosol box use on HCP workload, 2) identify factors associated with HCP workload when using an aerosol box, and 3) describe the challenges perceived by HCPs of aerosol box use.
Simulation-based randomized trial, conducted from May to December 2021.
Four pediatric simulation centers.
Teams of two HCPs were randomly assigned to control (no aerosol box) or intervention groups (aerosol box).
Each team performed three scenarios requiring different pediatric airway management (bag-valve-mask [BVM] ventilation, laryngeal mask airway [LMA] insertion, and endotracheal intubation [ETI] with video laryngoscopy) on a simulated COVID-19 patient. National Aeronautics and Space Administration-Task Load Index (NASA-TLX) is a standard tool that measures subjective workload with six subscales.
A total of 64 teams (128 participants) were recruited. The use of aerosol box was associated with significantly higher frustration during LMA insertion (28.71 vs. 17.42; mean difference, 11.29; 95% CI, 0.92-21.66; p = 0.033). For ETI, there was a significant increase in most subscales in the intervention group, but there was no significant difference for BMV. Average NASA-TLX scores were all in the "low" range for both groups (range: control BVM 23.06, sd 13.91 to intervention ETI 38.15; sd 20.45). The effect of provider role on workloads was statistically significant only for physical demand ( p = 0.001). As the complexity of procedure increased (BVM → LMA → ETI), the workload increased in all six subscales ( p < 0.05).
The use of aerosol box increased workload during ETI but not with BVM and LMA insertion. Overall workload scores remained in the "low" range, and there was no significant difference between airway provider and assistant.
气溶胶盒旨在降低医疗保健提供者(HCP)在产生气溶胶的医疗程序(AGMP)中接触感染的风险,但人们对其对团队成员工作量的影响知之甚少。我们对一项前瞻性、多中心、随机对照试验的数据进行了二次分析,该试验评估了气溶胶盒的使用对 AGMP 期间 HCP 污染模式的影响。本研究的目的是:1)评估气溶胶盒使用对 HCP 工作量的影响,2)确定使用气溶胶盒时与 HCP 工作量相关的因素,3)描述 HCP 使用气溶胶盒时感知到的挑战。
基于模拟的随机试验,于 2021 年 5 月至 12 月进行。
四个儿科模拟中心。
两组 HCP 被随机分配到对照组(无气溶胶盒)或干预组(气溶胶盒)。
每个团队在模拟 COVID-19 患者上执行三个需要不同儿科气道管理(球囊面罩通气[BVM]、喉罩气道[LMA]插入和视频喉镜引导下气管插管[ETI])的场景。美国国家航空航天局-任务负荷指数(NASA-TLX)是一种标准工具,使用六个子量表测量主观工作量。
共招募了 64 个团队(128 名参与者)。LMA 插入时使用气溶胶盒与明显更高的挫败感相关(28.71 与 17.42;平均差异,11.29;95%CI,0.92-21.66;p=0.033)。对于 ETI,干预组的大多数子量表都有显著增加,但 BMV 没有显著差异。两组的平均 NASA-TLX 评分均处于“低”范围(范围:对照组 BMV 23.06,标准差 13.91 至干预组 ETI 38.15;标准差 20.45)。提供者角色对工作量的影响仅在体力需求方面具有统计学意义(p=0.001)。随着程序复杂性的增加(BVM→LMA→ETI),所有六个子量表的工作量都增加(p<0.05)。
气溶胶盒的使用增加了 ETI 期间的工作量,但 BVM 和 LMA 插入时则不然。总体工作量评分仍处于“低”范围,气道提供者和助手之间没有显著差异。